Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses

Clinical trials on the use of COVID-19 convalescent plasma remain inconclusive. While data on safety is increasingly available, evidence for efficacy is still sparse. Subgroup analyses hint to a dose-response relationship between convalescent plasma neutralizing antibody levels and mortality. In par...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlickeiser, Stephan, Schwarz, Tatjana, Steiner, Sophie, Wittke, Kirsten, Al Besher, Nabeel, Meyer, Oliver, Kalus, Ulrich, Pruß, Axel, Kurth, Florian, Zoller, Thomas, Witzenrath, Martin, Sander, Leif Erik, Müller, Marcel A., Scheibenbogen, Carmen, Volk, Hans-Dieter, Drosten, Christian, Corman, Victor M., Hanitsch, Leif G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878374/
https://www.ncbi.nlm.nih.gov/pubmed/33584731
http://dx.doi.org/10.3389/fimmu.2020.628971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878374/
https://www.ncbi.nlm.nih.gov/pubmed/33584731
http://dx.doi.org/10.3389/fimmu.2020.628971

Ejemplares similares